Vacancy at Biocon for Technology Transfer – Formulations
Technology Transfer – Formulations
Experience: 7 – 10 years
Qualification : M. Pharm Pharmaceutics
Preparation on technology transfer strategy with timelines, gap analysis, technology dossier and execution plan for both Potent & Non-potent compounds.
QbD based optimization of process by following DOE designs to ensure robust manufacturing process before transfer to site.
Monitoring execution of the TT demo batches, optimization batches & registration batches for USA & EU markets.
Experience of handling both Solid oral as well parenteral products would be an added advantage.
Send Resumes: [email protected]
Biocon, India’s largest biotech company is focused on delivering affordable innovation. Biocon’s key innovations include an indigenous recombinant human insulin based on proprietary fermentation technology, INSUGEN®, insulin analogue Glargine, BASALOG® and India’s first indigenously produced monoclonal antibody BioMAb-EGFR®, for head & neck cancer. INSUPen® is a next generation affordable insulin delivery device introduced in India by Biocon. Over the decades, Biocon has successfully evolved into an emerging global biopharma enterprise, serving its partners and customers in over 100 countries. Biocon has rapidly developed a robust novel and biosimilars pipeline, focusing on Diabetes, Oncology and auto-immune diseases, which has several molecules at different stages of the development cycle.
It has successfully developed and taken a range of novel biologics, biosimilars, differentiated small molecules and affordable recombinant human insulin and analogs from ‘Lab to Market’. Some of its key brands are INSUGEN®(rh-insulin), BASALOG® (Glargine), CANMAb™ (Trastuzumab), BIOMAb-EGFR™ (Nimotuzumab) and ALZUMAb™(Itolizumab), a ‘first in class’ anti-CD6 monoclonal antibody. It has a rich pipeline of biosimilars and novel biologics at various stages of development including a high potential Insulin Tregopil.
For pharma Jobs: Click here
For Online shopping offers : Click Here